Scholarlink

Background <p>Cancer remains a major global health burden, contributing significantly to illness and death worldwide. Although current treatments such as chemotherapy, radiation therapy, and surgery have improved patient outcomes, they are frequently limited by severe side effects, drug resistance, and damage to healthy tissues. These challenges have prompted the search for novel, safer, and more targeted therapeutic options.</p> Main body <p>Rhamnetin, a naturally occurring compound found in various plants, has emerged as a promising candidate in cancer therapy due to its diverse range of biological activities. It has demonstrated the ability to induce programmed cell death in cancer cells, inhibit the formation of new blood vessels that support tumor growth, and prevent the transition of cancer cells to more invasive forms. Rhamnetin also regulates oxidative stress and mitochondrial function, contributing to its anticancer effects. Notably, it appears to preferentially affect cancerous cells while minimizing harm to normal tissues, suggesting a more targeted therapeutic profile. In addition to its individual therapeutic properties, rhamnetin has shown potential in enhancing the effectiveness of conventional treatments. By sensitizing cancer cells to existing therapies, it may help overcome resistance and improve overall treatment outcomes. Despite these promising effects, its clinical application remains limited by poor absorption, rapid metabolism, and low bioavailability. Recent advancements in drug delivery systems, including the use of nanoparticles and liposomes, offer promising strategies to address these limitations. These technologies have the potential to improve the stability, absorption, and targeting of rhamnetin, thereby enhancing its therapeutic value.</p> Conclusion <p>Rhamnetin represents a compelling natural compound with significant anticancer potential. Its ability to selectively target cancer cells, modulate multiple cancer-related pathways, and improve the efficacy of conventional treatments positions it as a valuable candidate for future cancer therapies. Continued research into optimized delivery methods and clinical applications is essential to fully harness its benefits in cancer treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rhamnetin is a multifaceted flavonoid with potential in cancer therapy: current insights and future directions

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月13日

查看全文
  • Mohammed A. Abdel-Rasol,
  • Mohammed Y.I. Al-Hamadani,
  • Zeinab A. Ibrahim,
  • Wael M. El-Sayed

摘要

Background

Cancer remains a major global health burden, contributing significantly to illness and death worldwide. Although current treatments such as chemotherapy, radiation therapy, and surgery have improved patient outcomes, they are frequently limited by severe side effects, drug resistance, and damage to healthy tissues. These challenges have prompted the search for novel, safer, and more targeted therapeutic options.

Main body

Rhamnetin, a naturally occurring compound found in various plants, has emerged as a promising candidate in cancer therapy due to its diverse range of biological activities. It has demonstrated the ability to induce programmed cell death in cancer cells, inhibit the formation of new blood vessels that support tumor growth, and prevent the transition of cancer cells to more invasive forms. Rhamnetin also regulates oxidative stress and mitochondrial function, contributing to its anticancer effects. Notably, it appears to preferentially affect cancerous cells while minimizing harm to normal tissues, suggesting a more targeted therapeutic profile. In addition to its individual therapeutic properties, rhamnetin has shown potential in enhancing the effectiveness of conventional treatments. By sensitizing cancer cells to existing therapies, it may help overcome resistance and improve overall treatment outcomes. Despite these promising effects, its clinical application remains limited by poor absorption, rapid metabolism, and low bioavailability. Recent advancements in drug delivery systems, including the use of nanoparticles and liposomes, offer promising strategies to address these limitations. These technologies have the potential to improve the stability, absorption, and targeting of rhamnetin, thereby enhancing its therapeutic value.

Conclusion

Rhamnetin represents a compelling natural compound with significant anticancer potential. Its ability to selectively target cancer cells, modulate multiple cancer-related pathways, and improve the efficacy of conventional treatments positions it as a valuable candidate for future cancer therapies. Continued research into optimized delivery methods and clinical applications is essential to fully harness its benefits in cancer treatment.